Cacti Therapeutics

Healing the Root of Chronic Pain
Boston, Dallas

About Cacti Therapeutics

We are an early-stage pharmaceutical company creating novel therapies for chronic pain, inflammation and headache disorders.

Tagged with

Team

Problem statement

Chronic pain is the #1 reason people seek healthcare. Our novel, non-addictive medicines and therapies aim to disrupt the $90 billion global market for pain pharmaceuticals.

Traction information

- Assembled a team of worldwide experts in AI drug development, plant medicine, pain neurobiology and psychiatry, each with a career focused on reducing human suffering. Our team has more than 25 years of combined training under Clifford Woolf, MD, PhD, the Harvard Med School professor who first described how chronic pain is driven by central sensitization.
- Developed a transformative pharmaceutical development platform to address chronic pain by treating its physiological and psychological drivers.
- Began biological proof of concept experiments with our patented, first-in-class analgesic compounds.

Updates

Kavya Sharman has visited this profile using a private link.
Added about 2 months ago
Kavya Sharman has visited this profile using a private link.
Added about 2 months ago
Lyndon Lay has visited this profile using a private link.
Added 2 months ago
Megan Boyd (CTR) has visited this profile using a private link.
Added 2 months ago
JJ Kasper has visited this profile using a private link.
Added 5 months ago
Michael Madigan has visited this profile using a private link.
Added 5 months ago
Chris has visited this profile using a private link.
Added 6 months ago
Joe Magyer has visited this profile using a private link.
Added 6 months ago
dafadfasfdfadsfad has visited this profile using a private link.
Added 6 months ago
Mark Thaler has visited this profile using a private link.
Added 6 months ago
Pitch is a Capital Factory product. © Capital Factory 2024. Privacy policy.